Brief: Ambu Expects Organic Revenue Growth Of 10-13% In 2025/26

Ambu A/S

05/11/2025 06:04

Nov 5 (Reuters) - Ambu A/S AMBUb.CO:

Q4 REVENUE DKK 1,466 MILLION VERSUS DKK 1,387 MILLION YEAR AGO

Q4 EBIT BEFORE SPECIAL ITEMS DKK 147 MILLION VERSUS DKK 147 MILLION YEAR AGO

Q4 ADJUSTED EBIT MARGIN 10.0% VERSUS COMPANY CONSENSUS 12.6%

2025/26 FINANCIAL GUIDANCE: ORGANIC REVENUE GROWTH: 10-13%

ENDOSCOPY SOLUTIONS INCREASED ORGANICALLY BY 12.4% (14.5%)

RESPIRATORY BUSINESS GROUP POSTED 8.8% (5.7%) ORGANIC GROWTH

UROLOGY, ENT, & GI BUSINESS GROUP POSTED 16.0% (24.8%) ORGANIC GROWTH

2025/26 FINANCIAL GUIDANCE: EBIT MARGIN B.S.I.: 12-14%

ANESTHESIA & PATIENT MONITORING INCREASED ORGANICALLY BY 6.4% (5.3%), DRIVEN BY SOLID VOLUME DEVELOPMENT

Source text: [ID:]

Further company coverage: AMBUb.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))